Benralizumab not effective reducing exacerbations in moderate to very severe COPD

Posted by on May 20, 2019 3:56 pm
Categories: health

New research shows that the asthma drug benralizumab failed to decrease annual COPD exacerbation rates for patients with moderate to very severe COPD, a history of frequent moderate and/or severe exacerbations, and eosinophilic inflammation.

Leave a Reply

Your email address will not be published.